The Pershing Square Sohn Cancer Research Alliance (PSSCRA) will open to receive applications for its 2027 Pershing Square Sohn Cancer Prize on Monday, September 21st, 2026. While the Prize originally started in an effort to support cancer research in the greater New York City area, the eligibility has expanded to include scientists across the United States. Scientists will each be awarded $750,000 over three years to empower them to pursue groundbreaking research at a stage when traditional funding is lacking.
Applicants must have:
- Between two to six years of experience running their own laboratories by the start date of the Prize (July 2027);
- A PhD, MD or MD-PhD (or equivalent);
- Access to an environment capable of conducting high-quality, high-impact cancer research, but investigators need not be specifically trained in cancer biology;
- Tenure-track faculty appointments at the level of Assistant or Associate Professor (or equivalent) at academic research institutions (or equivalent) in the United States of America;
- Applied to the Prize only once before (i.e. applicants may apply to the Pershing Square Sohn Cancer Prize a maximum of two times);
To Apply:
- This is an open RFP (UCSF may submit an unlimited number of applications).
- Follow application instructions in RFP, conferring with your Grants Officer as needed. Please notify your Grants Officer as soon as possible of your intention to apply to ensure that they will have enough time to support your application.
- LOI portal will open on September 21 and LOI deadline is Monday, October 26, 2026 at 5:00PM ET
- For those selected as a finalist, presentations will be held on April 13th and 14th in New York City
For more details on the application process, including the full eligibility criteria, please visit: https://pershingsquarephilanthropies.org/initiatives/programs/PSSCRA/page/application-guidelines.
Due Date